Moderna’s COVID-19 vaccine becomes third to be authorized by U.K. regulator

/ / News

Biotech Moderna’s COVID-19 vaccine has been authorized for emergency use by U.K. regulators, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regulatory Agency, or MHRA, approved the vaccine after a “thorough and rigorous assessment” by the regulator’s teams of scientists, including advice from the independent Commission on Human Medicines, the government said in a statement on Friday. Moderna’s vaccine marks the third to be approved for use by the MHRA and the second that uses the mRNA approach, which sends a message to cells telling them to create proteins that can generate an immune response. The Covid-19 vaccine developed by German biotech group BioNTech and U.S. drug company Pfizer also uses the mMRNA approach, and is being rolled out across the U.K which has been struggling to contain an outbreak of a more contagious strain of the virus that causes COVID-19. Another variant has been found in South Africa.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.